Axisresearch
List of Categories
- Aerospace & Defense
- Agriculture
- Animal Nutrition & Wellness
- Automation
- Automotive
- Chemical & Materials
- Consumer Goods and Services
- Electronics
- Energy & Mining
- Financial Services & Investment Intelligence
- Food & Beverage
- Healthcare
- Heavy Industry
- Home & Property Improvement
- Information & Communications Technology
- Investment Opportunities
- Manufacturing
- NEO
- Others
- Packaging
- Retail
- Technology & Media
- Transportation & Logistics
Sorted by Name
Publishers
Countries
Medical Simulation Market – Growth, Trends, and Forecast (2019 – 2024)
| Healthcare | Published by: Mordor Intelligence | Market: |
| 118 pages | Published: 07-06-2019 |
- Healthcare
- Mordor Intelligence
- 118 pages
- Published: 07-06-2019
Market Overview
The propelling factors for the growth of the medical simulation market include continuous technological advancements, increasing concerns over patient safety, and increasing demand for minimally invasive treatments.
The requirement of medical simulation in minimally invasive surgery has been established over the past few years. The minimally invasive techniques are becoming the standards of surgical techniques, at a very fast pace, for a number of surgical procedures. These MIS procedures involve smaller incisions leading to quicker recovery, which helps in the growth of the overall market.
The use of medical simulation devices, along with standardized patient simulators, has gained rapid growth over the last few years, mainly due to increasing technological advancements and their adoption in the field of healthcare. The barriers to adopting simulation products and services in hospitals include lack of funding, less time for simulation exercises, release from job environment, lack of management interest, etc.
The METIman simulator is found to be one of the most advanced and realistic simulators in the recent times, developed by the CAE simulators. Thus, the rise in various technological advancements in the field of medical simulation is increasing the applications in healthcare to train healthcare professionals, and as a result of which, the growth of the market studied is expected to propel over the forecast period.
Scope of the Report
As per the scope of the report, medical simulation is the modern day methodology for training healthcare professionals through the use of advanced educational technology. Medical simulation is experiential learning that every healthcare professional may need, but cannot be always engaged in during real-life patient care. The market of medical stimulation is growing with increasing healthcare facilities.
Key Market Trends
Laparoscopic Surgical Simulators is the Segment under Interventional/Surgical Simulators that is Expected to Grow the Fastest during the Forecast Period
Surgeons are found shifting to MIS, primarily laparoscopy and robotic surgery from open surgery. However, the MIS, primarily laparoscopy and robotic surgery, requires skilled surgeons to deliver successful procedures. There has been a rapid adoption of the MIS in the cholecystectomy, appendectomy, gastric bypass, ventral hernia repair, colectomy, prostatectomy,tubal ligation, hysterectomy, and myomectomy procedures. Thus, the increasing MIS surgeries and the need for skilled professionals have propelled the laparoscopic surgical simulators market.
There are also cardiac surgeries that have been a major challenge for surgeons because of the complex nature of the surgery and the need for highly skilled professionals. Also, there has been a change observed in general surgery training, with the shift from open surgery toward the endovascular and minimally invasive approaches to disease management. Therefore, further simulation is expected to reduce the risks associated with the complex operations of cardiothoracic surgery and help create a more efficient, thorough, and uniform curriculum for cardiothoracic surgery fellowships.
Asia-Pacific Registered the Fastest Growth and is Expected to follow the Same Trend over the Forecast Period
Asia-Pacific is projected to exhibit the fastest growth, due to the increasing demand for healthcare simulation and its related services. The emerging economies of India and China are expected to majorly boost the market, due to the growing thrust on medical studies and research. In addition, the ease of doing business in Asian countries is high, due to the availability of high labor and low manufacturing cost. This is an important factor that is estimated to augment the market in Asia-Pacific.
Competitive Landscape
The market is highly fragmented with many players. With many small and medium players, the competition is high. The market has been experiencing the entry of new players over the last few years, owing to the rising popularity of simulation technology. The existing players are differentiating on the basis of price, quality, and technology.
Reasons to Purchase this report:
– The market estimate (ME) sheet in Excel format
– Report customization as per the client’s requirements
– 3 months of analyst support
1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Continuous Technological Advancements
4.2.2 Increasing Concerns over Patient Safety
4.2.3 Increasing Demand for Minimally Invasive Treatments
4.3 Market Restraints
4.3.1 High Cost of Simulators
4.3.2 Reluctance to Adopt New Training Methods
4.3.3 Limited Availability of Funds, Especially in the Developing and Underdeveloped Countries
4.4 Porter’s Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 By Products and Services
5.1.1 Products
5.1.1.1 Interventional/Surgical Simulators
5.1.1.1.1 Laparoscopic Surgical Simulators
5.1.1.1.2 Gynecology Surgical Simulators
5.1.1.1.3 Cardiac Surgical Simulators
5.1.1.1.4 Arthroscopic Surgical Simulators
5.1.1.1.5 Other Products
5.1.1.2 Task Trainers
5.1.1.3 Other Products and Services
5.1.2 Services and Software
5.1.2.1 Web-based Simulation
5.1.2.2 Medical Simulation Software
5.1.2.3 Simulation Training Services
5.1.2.4 Other Services and Software
5.2 By Technology
5.2.1 High-fidelity Simulators
5.2.2 Medium-fidelity Simulators
5.2.3 Low-fidelity Simulators
5.3 By End User
5.3.1 Academic and Research Institutes
5.3.2 Hospitals
5.4 Geography
5.4.1 North America
5.4.1.1 United States
5.4.1.2 Canada
5.4.1.3 Mexico
5.4.2 Europe
5.4.2.1 Germany
5.4.2.2 United Kingdom
5.4.2.3 France
5.4.2.4 Italy
5.4.2.5 Spain
5.4.2.6 Rest of Europe
5.4.3 Asia-Pacific
5.4.3.1 China
5.4.3.2 Japan
5.4.3.3 India
5.4.3.4 Australia
5.4.3.5 South Korea
5.4.3.6 Rest of Asia-Pacific
5.4.4 Middle East & Africa
5.4.4.1 GCC
5.4.4.2 South Africa
5.4.4.3 Rest of Middle East & Africa
5.4.5 South America
5.4.5.1 Brazil
5.4.5.2 Argentina
5.4.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 3D Systems
6.1.2 Canadian Aviation Electronics (CAE)
6.1.3 Gaumard Scientific Company Inc.
6.1.4 Kyoto Kagaku Co. Ltd
6.1.5 Laerdal Medical
6.1.6 Limbs & Things Ltd
6.1.7 Mentice AB
6.1.8 Simulab Corporation
6.1.9 Simulaids Inc.
6.1.10 Nasco
7 MARKET OPPORTUNITIES AND FUTURE TRENDS
MARKET SEGMENTATION
By Products and Services
Products
Interventional/Surgical Simulators
Laparoscopic Surgical Simulators
Gynecology Surgical Simulators
Cardiac Surgical Simulators
Arthroscopic Surgical Simulators
Other Products
Task Trainers
Other Products and Services
Services and Software
Web-based Simulation
Medical Simulation Software
Simulation Training Services
Other Services and Software
By Technology
High-fidelity Simulators
Medium-fidelity Simulators
Low-fidelity Simulators
By End User
Academic and Research Institutes
Hospitals
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East & Africa
GCC
South Africa
Rest of Middle East & Africa
South America
Brazil
Argentina
Rest of South America
Revenue Cycle Management Market – Growth, Trends, and Forecast (2019 – 2024)
| Healthcare | Published by: Mordor Intelligence | Market: |
| 110 pages | Published: 07-06-2019 |
- Healthcare
- Mordor Intelligence
- 110 pages
- Published: 07-06-2019
Market Overview
The growth of the revenue cycle management (RCM) market is attributed to the increase in government initiatives to boost the adoption of RCM solutions, increasing revenue loss due to billing errors, and increasing adoption of EHR/EMR.
Revenue for healthcare providers depends on the accurate processing of medical claims. For improving the financial outcome, a healthcare organization needs to maintain a quality revenue cycle and insurance billing. The revenue cycle management team comprises of accounts receivable (A/R) management and denial management. With mounting pressure on hospitals to reduce cost, most of the care providers are losing revenue due to claim denials and their failure to submit or delay the denied claim. This has given an opportunity for specialty firms that provide revenue cycle management service.
Most hospitals are now dependent on third-party providers for denial management service, as they lack in the expert knowledge and the time to manage the reimbursement process. Most common billing errors include failure to verify insurance, filing an incomplete claim, coding errors, lack of specificity, and missing filing deadlines. Most of the care providers are now addressing the challenge by working with third-party medical billing professionals, who are expert in the overall revenue cycle management. With their expertise, these providers are able to increase the cash flow of their clients, which was otherwise neglected by the hospitals to resubmit the denied claims. It is estimated that over 90% of the claim denials can be prevented with support from providers (who have systems) and knowledge experts in this field. From the above, it can be concluded that the revenue loss to hospitals due to billing errors can be prevented by specialty revenue cycle management service providers. Thereby, this factor is expected to drive the market studied over the forecast period.
Scope of the Report
As per the scope of this report, the term revenue cycle management refers to solutions that support various hospitals and medical facilities to increase their revenue, by addressing the mistakes in billing, and by helping with efficient billing, documentation, and claim management.
Key Market Trends
Cloud-based is the Segment Under Deployment that is Expected to grow Fastest During the Forecast Period
The web-based segment held a maximum share in 2018 as it is installed off-site and is supervised by a third party. It is used over the internet and with a web browser, which does not require any additional storage or hardware. So, the data can be retrieved by various healthcare providers from different geographical locations.
The cloud-based segment is forecasted to show significant growth during the forecast period due to the flexibility and scalability offered by these solutions. The cloud-based delivery model makes the software extremely flexible regarding scalability (pay-as-you-go storage utilization). It simplifies and consolidates storage resources to reduce cost and enhance workflow, by eliminating departmental silos of clinical information. The storage and server power for the organization is hosted off-premise. The cloud vendor provides all the off-premise system support resources. This feature about cloud technology is a key market driver.
North America holds the Largest Market Share of the Revenue Cycle Management Market Currently and is Believed to Follow the Same Trend over the Forecast Period
The North American healthcare revenue cycle management market dominated the global market and is estimated to show a similar trend during the forecast period. This growth is due to factors like significant changes in regulations that have largely affected the finances, organization, and delivery of healthcare services. Most US healthcare providers are deploying revenue cycle management (RCM) systems that reduce the time taken for receiving payment after providing a service. The RCM that automates many activities previously done manually is saving time, which is a major factor for the growth of the market.
Competitive Landscape
The RCM market is moderately competitive, and consists of several major players, including Allscripts Healthcare Solutions, Athenahealth, Cerner Corporation, etc. The companies are implementing certain strategic initiatives, such as mergers, new product launches, acquisitions, and partnerships that help them in strengthening their market position. For instance, in April 2015, CareCloud entered into a partnership with Marshfield Clinic’s IT arm. CareCloud merged its medical billing software and services and Concierge practice management with Marshfield Clinic’s clinical solutions, such as electronic health record, population health management tool, and patient portal. The strategic partnership enabled the company to capitalize on market opportunities and rendered the company with profits.
Reasons to Purchase this report:
– The market estimate (ME) sheet in Excel format
– Report customization as per the client’s requirements
– 3 months of analyst support
1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Government Initiatives to Boost the Adoption of RCM Solutions
4.2.2 Increasing Revenue Loss Due to Billing Errors
4.2.3 Increasing Adoption of EHR/EMR
4.3 Market Restraints
4.3.1 High Pricing and Maintenance of RCM Solutions
4.3.2 Lack of Proper IT infrastructure
4.4 Porter’s Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 By Deployment
5.1.1 Web-based
5.1.2 Cloud-based
5.1.3 On-premise
5.2 By Function
5.2.1 Claims and Denial Management
5.2.2 Medical Coding and Billing
5.2.3 Electronic Health Record (EHR)
5.2.4 Clinical Documentation Improvement (CDI)
5.2.5 Insurance
5.2.6 Other Functions
5.3 By End User
5.3.1 Hospitals
5.3.2 Laboratories
5.3.3 Other End Users
5.4 Geography
5.4.1 North America
5.4.1.1 United States
5.4.1.2 Canada
5.4.1.3 Mexico
5.4.2 Europe
5.4.2.1 Germany
5.4.2.2 United Kingdom
5.4.2.3 France
5.4.2.4 Italy
5.4.2.5 Spain
5.4.2.6 Rest of Europe
5.4.3 Asia-Pacific
5.4.3.1 China
5.4.3.2 Japan
5.4.3.3 India
5.4.3.4 Australia
5.4.3.5 South Korea
5.4.3.6 Rest of Asia-Pacific
5.4.4 Middle East & Africa
5.4.4.1 GCC
5.4.4.2 South Africa
5.4.4.3 Rest of Middle East & Africa
5.4.5 South America
5.4.5.1 Brazil
5.4.5.2 Argentina
5.4.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Allscripts Healthcare Solutions
6.1.2 athenahealth, Inc.
6.1.3 Cerner Corporation
6.1.4 Conifer Health Solutions, LLC
6.1.5 Constellation Software
6.1.6 eClinicalWorks
6.1.7 Epic Systems Corporation
6.1.8 GE Healthcare
6.1.9 GeBBs Healthcare Solutions, Inc.
6.1.10 Mckesson Corporation
7 MARKET OPPORTUNITIES AND FUTURE TRENDS
MARKET SEGMENTATION
By Deployment
Web-based
Cloud-based
On-premise
By Function
Claims and Denial Management
Medical Coding and Billing
Electronic Health Record (EHR)
Clinical Documentation Improvement (CDI)
Insurance
Other Functions
By End User
Hospitals
Laboratories
Other End Users
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
]Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East & Africa
GCC
South Africa
Rest of Middle East & Africa
South America
Brazil
Argentina
Rest of South America
Next-generation Sequencing (NGS) – Growth, Trends, and Forecast (2019 – 2024)
| Healthcare | Published by: Mordor Intelligence | Market: |
| 115 pages | Published: 07-06-2019 |
- Healthcare
- Mordor Intelligence
- 115 pages
- Published: 07-06-2019
Market Overview
The major factors, such as increasing applications of NGS, speed, cost, and accuracy, efficient replacement for traditional technologies, and drug discovery applications demanding NGS technology are expected to drive the growth of the overall market.
The rapid speed, cost, and accuracy of the NGS technology help in the growth of the market. This is attained with the help of modern DNA sequencing technology, which has contributed to the sequencing of complete DNA sequences of numerous types and species of life. It is also found that NGS is significantly cheaper, quicker, and needs significantly lesser DNA, which helps in the overall growth of the market.
The NGS has the potential to accelerate the early detection of disorders and the identification of pharmacogenetics markers to customize its treatments.
There are various technological advancements in the field of medicine that are growing at a rapid pace and has led to the development of personalized medicine. There are a huge number of applications of next-generation sequencing in personalized medicine. Thus, the development of personalized medicine has opened many avenues for the application of NGS, which could accelerate the market growth.
The current market is also facing challenges, owing to the difficulty in management of large data and complications, associated with Big Data management. In addition, some of the ethical issues associated with whole-genome sequencing, coupled with the lack of awareness among people, are pulling back the growth of the market.
Scope of the Report
As per the scope of this report, NGS is a technology in which millions of DNA strands can be sequenced through massive parallelization; this technique is also known as high throughput sequencing. The low cost, high accuracy and speed, and precise results even from low sample input are the main advantages NGS offers over Sanger’s sequencing method. NGS is, therefore, being used to execute various applications, such as biomarker discovery, oncology studies, personalized medicine, and agricultural and animal research, among others. Thus, the NGS market has transformed the genomics and molecular diagnostics landscape.
Key Market Trends
Genetic Screening is the Segment Under Application that is Expected to Grow Fastest During the Forecast Period
In genetic screening, the NGS is highly useful in identifying monogenic diseases with locus heterogeneity, such as blindness, deafness, movement disorders, mitochondrial disease, hereditary cancers, etc. Therefore, NGS has a large number of varied applications through genetic screening in multiple disorders, but their affordability and availability in high-income and low-income countries may differ a lot. The entire genomes are being mapped at affordable costs. Thus, steady growth is expected in the forecast period.
The NGS is also emerging as a powerful promising pathogen-detection method for infectious-disease diagnostics. It helps in the identification and genomic characterization of bacteria, fungi, parasites, and viruses, without the need for prior knowledge of a specific pathogen, directly from clinical specimens. As the diseases caused by infections are increasing in the less-developed countries, the NGS-powered diagnosis of these infections has become the most promising method to detect these infectious diseases. The NGS also has applications in personalized medicine that has started becoming a reality and has been under application by various biotechnology companies.
Asia-Pacific is the Fastest-growing Market and is Expected to Follow the Same Trend over the Forecast Period
The market studied is expected to grow at the fastest pace in Asia-Pacific. The rising focus of the major market players is on delivering advanced, efficient NGS technology to the developing countries, in order to cater to the need for genomic medicines and whole genome sequencing for personalized medicine. In addition, the increasing adoption of NGS technology by the non-government and government bodies, along with increased investment of the private players, is expected to drive the Asian market.
Competitive Landscape
There are major biotech industries that are making large investments on evolving preventive vaccines and therapeutic vaccines that can stop or cure diseases, varying from viruses to cancers. The biotech industry, thus, uses the NGS to develop advanced diagnostic kits, in order to screen for pathological conditions and infectious diseases.
Reasons to Purchase this report:
– The market estimate (ME) sheet in Excel format
– Report customization as per the client’s requirements
– 3 months of analyst support
1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Application in the Clinical Diagnosis
4.2.2 Speed, Cost, and Accuracy to Spur the Market Growth
4.2.3 Efficient Replacement for Traditional Technologies (Microarrays)
4.2.4 Drug Discovery Applications Demanding NGS Technology
4.3 Market Restraints
4.3.1 Legal and Ethical Issues
4.3.2 Interpretation of Complex Data and Lack of Skilled Professionals
4.4 Porter’s Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 By Type of Sequencing
5.1.1 Whole Genome Sequencing
5.1.2 Targeted Resequencing
5.1.3 Whole Exome Sequencing
5.1.4 RNA Sequencing
5.1.5 CHIP Sequencing
5.1.6 De Novo Sequencing
5.1.7 Methyl Sequencing
5.2 By Product Type
5.2.1 Instruments
5.2.2 Reagents and Consumables
5.2.3 Services
5.3 By End User
5.3.1 Hospitals and Healthcare Institutions
5.3.2 Academics
5.3.3 Pharmaceutical and Biotechnology Companies
5.4 By Application
5.4.1 Drug Discovery/Personalized Medicine
5.4.2 Genetic Screening
5.4.3 Diagnostics/Infectious Diseases
5.4.4 Agriculture and Animal Research
5.4.5 Other Applications
5.5 Geography
5.5.1 North America
5.5.1.1 United States
5.5.1.2 Canada
5.5.1.3 Mexico
5.5.2 Europe
5.5.2.1 Germany
5.5.2.2 United Kingdom
5.5.2.3 France
5.5.2.4 Italy
5.5.2.5 Spain
5.5.2.6 Rest of Europe
5.5.3 Asia-Pacific
5.5.3.1 China
5.5.3.2 Japan
5.5.3.3 India
5.5.3.4 Australia
5.5.3.5 South korea
5.5.3.6 Rest of Asia-Pacific
5.5.4 Middle East & Africa
5.5.4.1 GCC
5.5.4.2 South Africa
5.5.4.3 Rest of Middle East & Africa
5.5.5 South America
5.5.5.1 Brazil
5.5.5.2 Argentina
5.5.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Agilent Technologies
6.1.2 DNASTAR Inc.
6.1.3 F. Hoffmann-La Roche Ltd
6.1.4 GATC Biotech AG
6.1.5 Illumina Inc.
6.1.6 Macrogen Inc.
6.1.7 Pacific Biosciences of California Inc.
6.1.8 PerkinElmer Inc.
6.1.9 Qiagen
6.1.10 Thermo Fisher Scientific Inc.
7 MARKET OPPORTUNITIES AND FUTURE TRENDS
MARKET SEGMENTATION
By Type of Sequencing
Whole Genome Sequencing
Targeted Resequencing
Whole Exome Sequencing
RNA Sequencing
CHIP Sequencing
De Novo Sequencing
Methyl Sequencing
By Product Type
Instruments
Reagents and Consumables
Services
By End User
Hospitals and Healthcare Institutions
Academics
Pharmaceutical and Biotechnology Companies
By Application
Drug Discovery/Personalized Medicine
Genetic Screening
Diagnostics/Infectious Diseases
Agriculture and Animal Research
Other Applications
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South korea
Rest of Asia-Pacific
Middle East & Africa
GCC
South Africa
Rest of Middle East & Africa
South America
Brazil
Argentina
Rest of South America
Rapid Diagnostic Kits Market Share – Growth, Trends, and Forecast (2019 – 2024)
| Healthcare | Published by: Mordor Intelligence | Market: |
| 118 pages | Published: 07-06-2019 |
- Healthcare
- Mordor Intelligence
- 118 pages
- Published: 07-06-2019
Market Overview
The propelling factors for the growth of the rapid diagnostic kits market include the increasing number of government initiatives for the diagnosis of infectious disease incidence, along with the rising need for fast detection of diseases, which are also contributing to the increasing demand for rapid diagnostic tests, across the world. In addition to this, the growth of government initiatives, such as awareness programs and funding research studies, has influenced the healthcare industry.
The government proactively invests in many of the research studies that include the diagnosis of infectious diseases. Thus, increasing government initiatives for the efficient diagnosis of infectious diseases help in driving the overall growth of the market studied.
The patients suffering from chronic diseases are found to have an increased risk of developing end-stage heart failure diseases. Therefore, the early identification and management of patients with chronic diseases are found to be important, in order to decrease morbidity and mortality. The early detection of diseases is possible with the screening programs targeting high-risk patients, such as patients with diabetes mellitus, hypertension, and elderly patients. Thus, there are several rapid diagnostic kits available for many chronic diseases, which diagnose the disease while it is asymptomatic, with no signs or symptoms.
The increase in home healthcare is driving the use of rapid diagnostics. This brings treatment and prevention care options to the patient’s home, thus, avoiding the long queue in hospitals. This saves the patients’ time and travel costs, thereby, driving the rapid diagnostics kits market.
Scope of the Report
As per the scope of the report, rapid medical diagnostic kits are used for detecting or diagnosing a wide range of infections, conditions, and diseases that the person might be suffering from. Moreover, these kits offer an accurate diagnosis for diseases, such as malaria, and conditions, such as diabetes and pregnancy. The rapidly growing medical diagnostics industry and high demand for the preventive management of infectious diseases caused by viruses and bacteria, worldwide, are some of the factors contributing to the growth of the rapid diagnostic kits market.
Key Market Trends
Veterinary testing is the segment under application that is expected to grow the fastest during the forecast period
There are several rapid diagnostic kits available in the market for veterinary testing. The range of different innovative technologies is available for real-time or rapid diagnosis of livestock diseases. The major advantage of rapid diagnostic kits is the cost, as costs less to test pets and other veterinary animals. All these benefits of rapid diagnostics kits are driving the veterinary segment of the market studied, which is expected to grow further during the forecast period.
The use of kits in home healthcare testing is also increasing every day, and no special skill is required to use the kits so patients can perform rapid diagnostic tests at home with the help of these kits, which are readily available in the market. Such benefits of the kits and the increasing adoption of the same by people are expected to help the market studied grow during the forecast period.
Asia-Pacific registered the fastest growth and is expected to follow the same trend over the forecast period
The Asia-Pacific region is predicted to witness high growth, due to the presence of a large base of patients with unmet medical needs in emerging economies, such as India and China. This is expected to help the Asia-Pacific rapid medical diagnostic kits market grow at the fastest rate during the forecast period. The increasing number of local manufacturers of RDT kits and the rising disease prevalence are propelling the need for rapid diagnostics, in turn, boosting the market growth over the forecast period.
Competitive Landscape
The rapid diagnostic kits market has leading companies, like Alere, BioMérieux, and Roche Diagnostics, among others. There are also several companies entering into the market. Also, several private companies are introducing innovative products to enter into the market. Various major companies based in the country have also contributed significantly to the market.
Reasons to Purchase this report:
– The market estimate (ME) sheet in Excel format
– Report customization as per the client’s requirements
– 3 months of analyst support
1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Government Initiatives for the Diagnosis of infectious Diseases
4.2.2 Rising Awareness Regarding Early Diagnosis among People
4.2.3 Shift in Technological and Commercial Environment
4.3 Market Restraints
4.3.1 Lack of Awareness Regarding Newer Rapid Diagnostic Tests
4.3.2 Failure to Eliminate the Need for Microscopy Diagnosis
4.4 Porter’s Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 By Technology
5.1.1 Flow Through
5.1.2 Solid Phase
5.1.3 Lateral Flow
5.1.4 Agglutination Assays
5.2 By Application
5.2.1 Hospitals and Clinical Testing
5.2.2 Home Testing
5.2.3 Veterinary Testing
5.3 Geography
5.3.1 North America
5.3.1.1 United States
5.3.1.2 Canada
5.3.1.3 Mexico
5.3.2 Europe
5.3.2.1 Germany
5.3.2.2 United Kingdom
5.3.2.3 France
5.3.2.4 Italy
5.3.2.5 Spain
5.3.2.6 Rest of Europe
5.3.3 Asia-Pacific
5.3.3.1 China
5.3.3.2 Japan
5.3.3.3 India
5.3.3.4 Australia
5.3.3.5 South korea
5.3.3.6 Rest of Asia-Pacific
5.3.4 Middle East & Africa
5.3.4.1 GCC
5.3.4.2 South Africa
5.3.4.3 Rest of Middle East & Africa
5.3.5 South America
5.3.5.1 Brazil
5.3.5.2 Argentina
5.3.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 ACON Laboratories Inc.
6.1.2 Abbott Laboratories
6.1.3 Alfa Scientific Designs Inc.
6.1.4 Artron Laboratories Inc.
6.1.5 Becton, Dickinson and Company
6.1.6 BTNX Inc.
6.1.7 Meridian Bioscience Inc.
6.1.8 Creative Diagnostics
6.1.9 McKesson Medical-Surgical Inc.
6.1.10 F. Hoffmann-La Roche Ltd
6.1.11 Zoetis Inc.
6.1.12 BioMerieux
7 MARKET OPPORTUNITIES AND FUTURE TRENDS
MARKET SEGMENTATION
By Technology
Flow Through
Solid Phase
Lateral Flow
Agglutination Assays
By Application
Hospitals and Clinical Testing
Home Testing
Veterinary Testing
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South korea
Rest of Asia-Pacific
Middle East & Africa
GCC
South Africa
Rest of Middle East & Africa
South America
Brazil
Argentina
Rest of South America
UK Wound Care Management Devices Market – Growth, Trends, and Forecast (2019 – 2024)
| Healthcare | Published by: Mordor Intelligence | Market: |
| 72 pages | Published: 07-06-2019 |
- Healthcare
- Mordor Intelligence
- 72 pages
- Published: 07-06-2019
Market Overview
The growth of the wound care management devices market is attributed due to the increase in the geriatric population, rising incidences of a chronic wound, and an increase in the number of surgeries.
In the United Kingdom, the prevalence of diabetes is around 6% of the overall population. According to the National Institute of Health, 1 in every 16 people in the United Kingdom is suffering from diabetes. Nearly one-third of the diabetics develop foot ulceration within a year of diagnosis. Diabetic foot’ refers to an infection, ulceration, and possible amputation of a foot or leg among diabetics. This infection, usually, is diagnosed in its later stages, which poses adverse socio-economic consequences for patients and their families. Extensive surveys indicate that about 40-70% of all lower extremity amputations are related to diabetes. Incidences of chronic wounds, especially foot ulcers, are common among the diabetic population. While more than 80,000 adults are expected to undergo a lower extremity amputation, diabetics are 10 times more likely to undergo amputation at some point in their lifetime. The diabetic population is likely to grow in the United Kingdom, which, in turn, is anticipated to drive the market for wound care management devices during the forecast period.
Scope of the Report
As per the scope of this report, the term wound care management is the utilization of different products and technologies for the healing of wounds. In simple words, it is the treatment given for both acute and chronic wounds.
Key Market Trends
Long-term Care Facility is the Segment Under Deployment that is Expected to Grow Fastest during the Forecast period
The hospital and specialty wound clinic segment held a maximum share in 2018. This segment holds the largest share, owing to high demand for these devices in all types of healthcare centers and including out-patient centers, specialty hospitals, and community health centers. High rate of hospitalizations and increase in demand for surgeries, especially minimally invasive surgeries, are the key factors responsible for the high demand for wound management devices and consumables in hospitals and all other healthcare settings. The long-term care facility segment is forecast to show significant growth during the forecast period.
Competitive Landscape
The UK wound care management devices market is moderately competitive and consists of several major players. The companies are implementing certain strategic initiatives, such as mergers, new product launches, acquisitions, and partnerships that help them in strengthening their market position. For instance, in December 2017, Smith & Nephew announced the European launch of MolecuLight i:X, which is a handheld imaging device that can be used to instantly measure wound surface area and visualize the presence of potentially harmful bacteria in it.
Reasons to Purchase this report:
– The market estimate (ME) sheet in Excel format
– Report customization as per the client’s requirements
– 3 months of analyst support
1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increase in the Geriatric Population
4.2.2 Rising Incidences of Chronic Wound
4.2.3 Increase in the Number of Surgeries
4.3 Market Restraints
4.3.1 High-cost Procedures
4.3.2 Lack of Proper Reimbursements
4.3.3 Reluctance toward the Acceptance of New Technologies
4.4 Porter’s Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 By Product
5.1.1 Advanced Wound Management Product
5.1.1.1 Advanced Wound Dressing
5.1.1.1.1 Foam Dressing
5.1.1.1.2 Hydrocolloid Dressing
5.1.1.1.3 Film Dressing
5.1.1.1.4 Alginate Dressing
5.1.1.1.5 Hydrogel Dressing
5.1.1.1.6 Other Advanced Dressings
5.1.1.2 Wound Therapy Device
5.1.1.2.1 Pressure Relief Device
5.1.1.2.2 Negative Pressure Wound Therapy (NPWT) System
5.1.1.2.2.1 Conventional NPWT System
5.1.1.2.2.2 Disposable NPWT System
5.1.1.2.3 Oxygen and Hyperbaric Oxygen Equipment
5.1.1.2.4 Electrical Stimulation Device
5.1.1.2.5 Other Therapy Devices
5.1.1.3 Surgical Wound Care Product
5.1.1.3.1 Suture and Staple
5.1.1.3.2 Tissue Adhesive, Sealant, and Glue
5.2 End User
5.2.1 Hospital and Specialty Wound Clinic
5.2.2 Long-term Care Facility
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Johnson & Johnson
6.1.2 KCI Inc.
6.1.3 3M
6.1.4 Smith &Nephew
6.1.5 Convatec Inc.
6.1.6 Medtronic plc
6.1.7 Beiersdorf
6.1.8 Coloplast A/S
6.1.9 Molnlycke Health Care
6.1.10 Derma Sciences
7 MARKET OPPORTUNITIES AND FUTURE TRENDS
MARKET SEGMENTATION
By Product
Advanced Wound Management Product
Advanced Wound Dressing
Foam Dressing
Hydrocolloid Dressing
Film Dressing
Alginate Dressing
Hydrogel Dressing
Other Advanced Dressings
Wound Therapy Device
Pressure Relief Device
Negative Pressure Wound Therapy (NPWT) System
Conventional NPWT System
Disposable NPWT System
Oxygen and Hyperbaric Oxygen Equipment
Electrical Stimulation Device
Other Therapy Devices
Surgical Wound Care Product
Suture and Staple
Tissue Adhesive, Sealant, and Glue
End User
Hospital and Specialty Wound Clinic
Long-term Care Facility
Spectacle Lens Market – Growth, Trends, and Forecast (2019 – 2024)
| Healthcare | Published by: Mordor Intelligence | Market: |
| 115 pages | Published: 07-06-2019 |
- Healthcare
- Mordor Intelligence
- 115 pages
- Published: 07-06-2019
Market Overview
The growth of the global spectacle lens market is due to the increasing geriatric population and rising prevalence of optical disorders. Globally, the percentathe ge of elderly population increased from 5.6% to 8.6% between 1961 and 2011. According to the US Census Bureau’s Statistics, among 7.3 billion people in the world, in 2015 an estimated 8.5 %, or 617.1 million, were aged 65 years and older.
According to the WHO, currently, people have high life expectancy. By 2050, the world’s population aged 60 years and above is expected to reach a total of 2 billion. As of 2018, 125 million people are aged 80 years or older. As per the same source, by 2050, it is estimated that almost 120 million people will be living in China alone. The increase in the number of cases of ocular conditions, such as cataract and diabetic retinopathy, across the world, is assisting the market growth. According to the National Eye Institute, the United States recorded 7.7 million diabetic retinopathy cases and 24 million cataract cases, which are expected to reach 11.3 million and 38 million, respectively, by 2030. Hence, these factors are expected to propell the market growth over the forecast period.
Scope of the Report
This report includes an in-depth study of the global spectacle lens market (henceforth, referred to as the market studied’). As per the scope of the report, the spectacle lens is the corrective lens, which is used to correct eye problems and improve vision. Common indications of the use of spectacle lens include myopia, astigmatism, presbyopia, and hypermetropia.
Key Market Trends
Prescription Glass Segment is Expected to Exhibit Fastest Growth Rate over the Forecast Period
Prescription glasses refer to spectacles whose lenses have been made specifically to match the wearer’s defects of vision. According to a report published by the Vision Council of America, in 2015, 76.2% of American adults used vision correction. The report also states that 159.2 million people in the United States used prescription eyeglasses as a means of vision correction. In addition, on the basis of gender, 61.2% men in the United States used eyeglasses whereas 67.3% of women used prescription glasses (2015).
The price of prescription glasses generally ranges between USD 5-USD 30. It depends upon various factors, such as frame type, frame size, gender, material, weight, and prescription-type (single vision, bifocal, etc.). Some of the brands for prescription glasses include Vincent Chase, John Jacobs, Ray-Ban, Tom Ford, Persol, Calvin Klein, etc., which hold a major share of the prescription glass market.
North America Captured the Largest Market Share and is Expected to Retain its Dominance
North America dominated the overall spectacle lens market, owing to the speedy adoption of spectacles for vision care in the region, growing geriatric population, and increasing awareness. The United States accounted to be the major contributor to the North American spectacle lens market. The Vision Council of America reported that there were 188.7 million Americans wearing some form of vision correction in the country, which was just over 3 out of every 4 adults (as in 2015). Moreover, according to the Vision Council of America, the usage increased the most for OTC readers (from 29.8 million in 2014 to 30.9 million in 2015) and Rx sunglasses (from 27.4 million in 2014, to 29.1 million in 2015). In addition, the usage of prescription glasses increased from 156.5 million in 2014 to 159.2 million in 2015 in the country. Thus, all the aforementioned factors are expected to propel the growth of the US spectacle lens market.
Competitive Landscape
The spectacle lens market is highly competitive and consists of several major players. In terms of market share, few of these major players currently dominate the market. The presence of major market players, such as Carl Zeiss Meditec AG, Essilor International SA, Hoya Vision Care Company, Vision Ease, and Seiko Optical Products Co. Ltd is, in turn, increasing the overall competitive rivalry of the market. The product advancements and improvement in the spectacle lens market by the major players is increasing the competitive rivalry.
Reasons to Purchase this report:
– The market estimate (ME) sheet in Excel format
– Report customization as per the client’s requirements
– 3 months of analyst support
1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Rising Aging Population
4.2.2 Increasing Prevalence of Optical Disorders
4.3 Market Restraints
4.3.1 Poor Quality of Lens
4.4 Industry Attractiveness Porter’s Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 By Type
5.1.1 Single Vision
5.1.2 Bifocal
5.1.3 Trifocal
5.1.4 Progressive
5.2 By Coating Type
5.2.1 Anti-reflective Coating
5.2.2 Scratch-resistant Coating
5.2.3 Anti-fog Coating
5.2.4 UV Protection
5.2.5 Other Coatings
5.3 By Usage
5.3.1 Prescription Glass
5.3.2 OTC Reading Glass
5.4 Geography
5.4.1 North America
5.4.1.1 United States
5.4.1.2 Canada
5.4.1.3 Mexico
5.4.2 Europe
5.4.2.1 United Kingdom
5.4.2.2 Germany
5.4.2.3 France
5.4.2.4 Italy
5.4.2.5 Spain
5.4.2.6 Rest of Europe
5.4.3 Asia-Pacific
5.4.3.1 China
5.4.3.2 Japan
5.4.3.3 India
5.4.3.4 Australia
5.4.3.5 South Korea
5.4.3.6 Rest of Asia-Pacific
5.4.4 Middle East & Africa
5.4.4.1 GCC
5.4.4.2 South Africa
5.4.4.3 Rest of Middle East & Africa
5.4.5 South America
5.4.5.1 Brazil
5.4.5.2 Argentina
5.4.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Carl Zeiss Meditec AG
6.1.2 Essilor International SA
6.1.3 Hoya Vision Care Company
6.1.4 Vision Ease
6.1.5 Seiko Optical Products Co. Ltd
6.1.6 Rodenstock GmbH
6.1.7 GKB Ophthalmics Ltd
7 MARKET OPPORTUNITIES AND FUTURE TRENDS
MARKET SEGMENTATION
By Type
Single Vision
Bifocal
Trifocal
Progressive
By Coating Type
Anti-reflective Coating
Scratch-resistant Coating
Anti-fog Coating
UV Protection
Other Coatings
By Usage
Prescription Glass
OTC Reading Glass
Geography
North America
United States
Canada
Mexico
Europe
United Kingdom
Germany
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East & Africa
GCC
South Africa
Rest of Middle East & Africa
South America
Brazil
Argentina
Rest of South America